Document is current
Any future updates will be listed below
-
Authors
Liang, Xiao
Xiao, Jun https://orcid.org/0000-0003-4463-9845
Li, Xuzichao
Liu, Yujie https://orcid.org/0000-0002-7908-6024
Lu, Yao
Wen, Yanan
Li, Zexing
Che, Xing https://orcid.org/0000-0002-7427-9038
Ma, Yongjian
Zhang, Xingyan
Zhang, Yi
Jian, Deng
Wang, Peihui https://orcid.org/0000-0001-6853-2423
Xuan, Chenghao
Yu, Guimei https://orcid.org/0000-0002-1322-8288
Li, Long https://orcid.org/0000-0002-4727-9307
Zhang, Heng https://orcid.org/0000-0003-1112-7149
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China
National Natural Science Foundation of China Grants
- License Information
-
More Information
Article History
Received: 2 April 2022
Accepted: 29 July 2022
First Online: 18 August 2022
Competing interests
: X.C. is the founder of YDS Pharmatech. The remaining authors declare no competing interests.
